EGFR and non-small cell lung carcinoma: Therefore, an accurate, rapid, and EGFR-specific variant test such as the IdyllaTM EGFR Mutation Test could be a beneficial and cost-effective approach in facilitating treatment decisions in patients with resectable early-stage NSCLC.